Determination of bulleyaconitine A in plasma by a sensitive LC-MS/MS method and its application to an oral pharmacokinetic study in rats

被引:4
作者
Wang, Qi [1 ,2 ,4 ]
Tan, Bo [3 ]
Gong, Yijuan [1 ,2 ]
Ji, Guoxia [1 ,2 ,4 ]
Zhang, Yun [1 ,2 ]
Yang, Ping [3 ]
Li, Wei [4 ]
Shen, Teng [1 ,2 ]
机构
[1] Fudan Univ, Dept Pharmaceut, Sch Pharm,Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
[2] Fudan Univ, PLA, Shanghai 201203, Peoples R China
[3] Fudan Univ, Sch Pharm, Analyt Ctr, Shanghai 201203, Peoples R China
[4] Shandong Univ Tradit Chinese Med, Sch Pharm, Dept Pharmaceut Anal, Shandong 250355, Peoples R China
关键词
Rheumatoid arthritis; Bulleyaconitine A; LC-MS/MS; Pharmacokinetics; INFLAMMATORY PAIN;
D O I
10.1016/j.jpba.2012.08.016
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed and validated for the quantification of bulleyaconitine A (BLA) concentration in rat plasma. An aliquot of 100 mu L plasma sample was prepared by liquid-liquid extraction with diethyl ether. Chromatographic separation was accomplished on a Phenomenex Luna C-18 column (50 mm x 2.00 mm, 5 mu m) utilizing a isocratic mobile phase consisting of (A) 0.1% formic acid in methanol and (B) formic acid in water. Detection was performed by multiple reaction monitoring (MRM) mode using electrospray ionization in the positive ion mode. The optimized fragmentation transitions for MRM were m/z 644.4 -> m/z 584.3 for BLA and m/z 632.4 -> m/z 572.3 for mesaconitine (IS). The method was linear over the concentration range of 0.02-20.0 ng/mL. The intra and inter-day variance are less than 6.1% and accuracy is within +/- 9.0%. The validated method was successfully applied to pharmacokinetic study in rat after single oral administration of 40 mu g/kg of BLA and the oral pharmacokinetic data of BLA have been demonstrated for the first time. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:202 / 206
页数:5
相关论文
共 13 条
[1]  
[Anonymous], 2011, Science Medicines Health, Guideline on bioanalytical method validation.
[2]  
Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104
[3]   Nociceptor-specific gene deletion reveals a major role for Nav1.7 (PN1) in acute and inflammatory pain [J].
Nassar, MA ;
Stirling, LC ;
Forlani, G ;
Baker, MD ;
Matthews, EA ;
Dickenson, AH ;
Wood, JN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12706-12711
[4]  
TANG X-C, 1986, Yaoxue Xuebao, V21, P886
[5]  
US FDA, 2001, GUID IND BIOAN METH
[6]   Use of bulleyaconitine A as an adjuvant for prolonged cutaneous analgesia in the rat [J].
Wang, Chi-Fei ;
Gerner, Peter ;
Schmidt, Birgitta ;
Xu, Zhen Zhong ;
Nau, Carla ;
Wang, Sho-Ya ;
Ji, Ru-Rong ;
Wang, Ging Kuo .
ANESTHESIA AND ANALGESIA, 2008, 107 (04) :1397-1405
[7]   Bulleyaconitine A isolated from Aconitum plant displays long-acting local anesthetic properties in vitro and in vivo [J].
Wang, Chi-Fei ;
Gerner, Peter ;
Wang, Sho-Ya ;
Wang, Ging Kuo .
ANESTHESIOLOGY, 2007, 107 (01) :82-90
[8]   A pharmacokinetic study of intramuscular administration of bulleyaconitine a in healthy volunteers [J].
Weng, WY ;
Xu, HN ;
Huang, JM ;
Wang, GQ ;
Shen, T ;
Zhang, HF .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (04) :747-749
[9]   Determination of bulleyaconitine A in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry [J].
Weng, WY ;
Xu, HN ;
Huang, JM ;
Wang, GQ ;
Shen, T ;
Zhang, JF .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 816 (1-2) :315-320
[10]   Voltage-gated sodium channels and pain pathways [J].
Wood, JN ;
Boorman, JP ;
Okuse, K ;
Baker, MD .
JOURNAL OF NEUROBIOLOGY, 2004, 61 (01) :55-71